MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$464,110K
Net Income
$17,685K
Net Profit Margin
3.81%
EPS
$0.69
Unit: Thousand (K) dollars
Revenue Breakdown
Cardio And Vascular
Cardiac Rhythm Management Neurom...
Other Markets
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-07-03
2026-04-03
2025-12-31
2025-09-26
Sales
464,110
439,580
472,060
467,691
Cost of sales
351,168
329,985
347,304
341,531
Gross profit
112,942
109,595
124,756
126,160
Selling, general and administrative
57,699
58,711
57,214
50,451
Research, development and engineering
11,278
16,243
10,109
10,949
Restructuring charges
-
-
281
-
Acquisition and integration costs
-
-
-639*
-
Other general expenses (gains)
-
-
1,857*
-
Restructuring and other charges
9,437
2,772
1,498
8,321
Total operating expenses
78,414
77,726
68,821
69,721
Operating income
34,528
31,869
55,935
56,439
Interest expense
10,135
9,734
9,280
9,367
(gain) loss on equity investments
42
-1,468
327
50
Other loss, net (see note 6)
-1,144
-316
-175
-1,130
Income from continuing operations before taxes
23,291
20,351
46,807
45,992
Provision (benefit) for income taxes
-314
3,845
-1,801
6,314
Income from continuing operations
23,605
16,506
48,608
39,678
Loss from discontinued operations, net of tax
0
0
0
0
Net income
23,605
16,506
48,608
39,678
Foreign currency translation gain (loss)
-5,576
-10,654
-
-1,857
Change in fair value of cash flow hedges, net of tax
-344
-2,891
-
-346
Other comprehensive income (loss)
-5,920
-13,545
-
-2,203
Comprehensive income
17,685
2,961
-
37,475
Basic EPS
0.69
0.48
-0.776
1.13
Diluted EPS
0.69
0.48
-0.729
1.11
Basic Average Shares
34,010,000
34,278,000
34,908,000
35,081,000
Diluted Average Shares
34,145,000
34,433,000
37,139,000
35,608,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Cardio And Vascular
$280,308K
(-2.28%↓ Y/Y)
Cardiac Rhythm
Management...
$173,712K
(1.00%↑ Y/Y)
Other Markets
$10,090K
(-42.80%↓ Y/Y)
Sales
$464,110K
(-2.60%↓ Y/Y)
Gross profit
$112,942K
(-12.55%↓ Y/Y)
Cost of sales
$351,168K
(1.10%↑ Y/Y)
Operating income
$34,528K
(-41.81%↓ Y/Y)
(gain) loss on equity
investments
$42K
(625.00%↑ Y/Y)
Total operating
expenses
$78,414K
(12.32%↑ Y/Y)
Income from continuing
operations before taxes
$23,291K
(-48.92%↓ Y/Y)
Provision (benefit) for
income taxes
-$314K
(-103.66%↓ Y/Y)
Interest expense
$10,135K
(3.91%↑ Y/Y)
Other loss, net (see
note 6)
-$1,144K
(71.26%↑ Y/Y)
Selling, general and
administrative
$57,699K
(9.02%↑ Y/Y)
Research, development and
engineering
$11,278K
(-20.80%↓ Y/Y)
Restructuring and other
charges
$9,437K
(255.98%↑ Y/Y)
Income from continuing
operations
$23,605K
(-36.22%↓ Y/Y)
Net income
$23,605K
(-36.22%↓ Y/Y)
Comprehensive income
$17,685K
(-80.37%↓ Y/Y)
Other comprehensive
income (loss)
-$5,920K
(-111.15%↓ Y/Y)
Foreign currency
translation gain (loss)
-$5,576K
(-111.77%↓ Y/Y)
Change in fair value of
cash flow hedges, net...
-$344K
(-105.98%↓ Y/Y)
Buy us a coffee
integer-registered-logo-svg
Integer Holdings Corp (ITGR)
integer-registered-logo-svg
Integer Holdings Corp (ITGR)